Group Risk Proposition Consultant

Zurich, the European headquartered global re/insurance company, said this morning its has secured a significant $1 billion quota share reinsurance

Zurich posts 13% BOP growth and $3.5bn net income in H1 2026 as Beazley deal nears completion. Strong investment returns and a 16% surge in P&C operating profit mask a deteriorating North America combined ratio - and a $10.8 billion acquisition that will reshape the group's specialty footprint. Zurich Insurance Group delivered business operating profit (BOP) of $4.8 billion for the first half of 2026, up 13% year on year, with net income attributable to shareholders rising 14% to $3.5 billion. The result was driven by strong P&C and Life performance globally, a 35% surge in the net investment result to $4.1 billion, and continuing momentum across all four operating regions. For US-based brokers and risk managers, however, the headline numbers sit alongside a regional performance that tells a more complicated story - and a pending acquisition that will fundamentally alter Zurich's specialty insurance positioning in the US market. North America: the weak spot in a strong global result. North America was the one region where Zurich's P&C performance moved in the wrong direction. North America P&C business operating profit fell 2% or $18 million year on year, driven by unfavourable loss experience and increased expenses, partially offset by higher investment results, according to the half-year report. The combined ratio in North America deteriorated 1.1 percentage points to 92.8% in the first half of 2026, compared with 91.7% in the same period a year earlier. The deterioration was driven by less favourable year-on-year prior-year reserve development, a higher loss ratio, and increased expenses, partially offset by lower catastrophe losses. Gross written premiums at the Farmers Exchanges - the policyholder-owned entity for which Zurich provides management services - grew 4% to $15.6 billion in H1 2026. For North American brokers placing complex commercial or specialty risks with Zurich, the combined ratio trend and reserve development changes are worth monitoring closely. They signal pressure on the technical result even at a point when global investment conditions have been unusually supportive - and the capacity benefit of the Beazley integration is still several months away. Beazley: the deal that changes the specialty equation. The more consequential near-term development for US market participants is Zurich's pending acquisition of Beazley plc, announced in March 2026 and approved by Beazley shareholders in April. Under the terms of the offer, Beazley shareholders will receive 1,310 pence per share in cash, for aggregate consideration of GBP 8.1 billion - approximately $10.8 billion - making it one of the largest insurance transactions in recent years. The acquisition is expected to close in the second half of 2026, subject to remaining regulatory approvals. To partly finance the deal, Zurich raised CHF 3.9 billion (approximately $4.9 billion) through the issuance of new shares in March 2026. The acquisition will make Beazley a wholly-owned subsidiary of Zurich Insurance Company Ltd. Beazley is a leading Lloyd's and specialty insurer with particular strength in cyber, professional liability, management liability, marine, property, and healthcare. Its integration into Zurich's platform will significantly expand the group's US specialty and E&S capabilities - adding capacity, product breadth, and distribution relationships that are directly relevant to US brokers placing complex risks. The Swiss Solvency Test ratio of 266% at June 30, 2026 does not yet reflect the equity capital raise completed in March. Also pending is Zurich's acquisition of the non-life insurance business of Generali's Irish operation, which trades under the RedClick brand, for EUR 337 million - expected to close by end of 2026 or early 2027. Group highlights. Group P&C BOP rose 16% to $2.8 billion, with insurance revenue up 8% to $25.0 billion and a combined ratio of 92.7% - marginally worse than the 92.4% recorded in H1 2025, with the expense ratio deteriorating 0.6 points to 30.6% due to changes in business mix. The loss ratio improved 0.3 points to 62.1%. Life BOP increased 23% to $1.3 billion, driven by strong growth in higher-margin protection and unit-linked products. Assets under management grew 4% to $333.4 billion. New business CSM rose 16% to $664 million, reflecting a deliberate shift into higher-margin product categories across all three lines. Farmers Management Services BOP grew 4% to $1.1 billion, consistent with gross earned premium growth at the Farmers Exchanges. Shareholders' equity increased 10% to $31.3 billion. The group paid a dividend of CHF 30 per share on April 14, 2026, as approved at the April 8 AGM. What it means for US brokers. The tension in Zurich's H1 2026 result for US brokers is temporal: the North America combined ratio is deteriorating now, while the Beazley capacity benefit is 12 or more months away. A continued adverse reserve development trend would typically signal underwriting appetite changes ahead of renewals - the kind of shift that brokers placing complex commercial, cyber, D&O, or E&O risks need early visibility on. The Beazley integration will ultimately bring significant additional specialty capacity and expertise to the US market. But for the renewal cycle immediately ahead, the North America technical trend is the more operationally relevant data point.

Due to Finma enforcement: Zurich dismisses "more than 12 employees" The insurance group had remained silent for a long time. However, speaking to Bloomberg, Zurich CEO Mario Greco has now revealed that the company has dismissed "more than 12 employees" as a result of the Finma enforcement proceedings. Zurich CEO Mario Greco confirms the enforcement proceedings and multiple dismissals. (Image: zVg) Tuesday, 28 July 2026 07:42 Press play to listen to this content Finma has imposed a sales ban on certain life insurance policies offered by Zurich. The enforcement action was triggered after customers in Switzerland were sold policies - which are subject to strict regulatory requirements - at lower prices than had been agreed with Finma. "It is regrettable that we did not identify the issue ourselves, despite all the audits and controls we conduct," Mario Greco told Bloomberg. Agreed corrective measures had not been implemented, ultimately leading to the enforcement proceedings. As a consequence, the affected unit within Zurich's Swiss business is, for the time being, only allowed to service existing customers. It remains unclear how long the investigation will continue. The business unit generates an annual profit of around 20 million Swiss francs. Greco said the sales ban would therefore have "no impact" on the group's overall financial results. Zurich had initially declined to comment on the findings of an investigation by the Swiss newspaper SonntagsBlick. According to the newspaper, the focus of the investigation is believed to be deficiencies in the company's internal control system (ICS). It also reported that investment in the relevant platform had apparently been cut back in recent years. Zurich Insurance Group is one of Switzerland's largest providers of occupational pensions. Its Vita collective foundation is its flagship pension vehicle, serving 27,000 affiliated companies and around 150,000 insured members. The foundation manages more than 22 billion francs in pension assets.